Grant: SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH
Primary Recipient
SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH
Amount
$983,591.00
Award Date
9/30/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
The Developmental Center for Neuroregulation in Alcohol Dependence (CeNiAD) grew from the clinical observation that the CNS active generic CM adrenoreceptor (AR) antagonist prazosin reduced or eliminated alcohol drinking in veterans with posttraumatic str
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | Primary recipient | $965,002.00 |
UNIVERSITY OF WASHINGTON | Sub-recipient | $18,589.00 |